Establishment Labs Holdings Inc (ESTA) - News Archive

Establishment Labs Unveils Preserv in Brazil, Pioneering a New Era in Breast Aesthetics and Reconstruction Establishment Labs Holdings Inc. (NASDAQ: ESTA), a prominent player in the field of medical technology, continue...

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is making waves in the medical technology sector, focusing on women s health and wellness, particularly in breast aesthetics and reconstruction. As the company gears up fo...

In an era where women s health and wellness have become focal points in medical innovation, Establishment Labs Holdings Inc. continues to make significant strides in the domain of breast aesthetics and reconstruction. T...

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a pioneering medical technology firm dedicated to enhancing women’s health and wellness, particularly in the realms of breast aesthetics and reconstruction, has recently...

In a remarkable milestone for women’s health and aesthetics, Establishment Labs Holdings Inc. (NASDAQ: ESTA) has announced that the first U.S. patients have successfully received breast augmentations using the newly FDA...

In a significant leap forward for breast aesthetics, Establishment Labs Holdings Inc. (NASDAQ: ESTA) has garnered approval from the U.S. Food and Drug Administration (FDA) for its innovative product line featuring Motiv...

Revolutionizing Breast Aesthetics: Establishment Labs FDA Approval Marks a New Era for Women s Health In an invigorating shift for the world of breast aesthetics and reconstruction, Establishment Labs Holdings Inc. a tr...

In an announcement today, Establishment Labs Holdings Inc, a medical technology company specializing in women s health, revealed amendments to its $225 million term loan facility with Oaktree Capital Management, L.P. Wh...

Establishment Labs Holdings Inc. (NASDAQ: ESTA), an international medical technology firm committed to enhancing women s health and wellness, has announced that it has commercially launched its revolutionary product, Mo...

Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023NEW YORK - Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medi...

Establishment Labs Holdings Inc., a global leader in medical technology, recently achieved a groundbreaking milestone in breast aesthetics and reconstruction. The company proudly announced that the Motiva Flora SmoothSi...

Establishment Labs Gains NMPA Approval for Motiva Implants, Marking Entry into Lucrative Chinese Aesthetics MarketNEW YORK - Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leading global medical technology company f...